Tempus AI Daiichi Sankyo Tie Up Highlights Precision Oncology Opportunity [Yahoo! Finance]
DAIICHI SANKYO S/ADR (DSNKY)
NASDAQ:AMEX Investor Relations:
daiichisankyo.com/media_investors/investor_relations/index.html
Company Research
Source: Yahoo! Finance
Tempus AI (NasdaqGS:TEM) and Daiichi Sankyo announced a collaboration to use Tempus' AI models in oncology drug development. The partnership centers on a novel antibody drug conjugate program, aiming to accelerate and refine patient selection in clinical trials. The companies plan to combine Tempus' multimodal AI foundation models with Daiichi Sankyo's oncology research and real world data assets. For investors tracking Tempus AI, this agreement adds another large biopharma name to the company's partner roster and reinforces its role as an AI data and analytics provider to drug developers. The focus on biomarker discovery and patient stratification places Tempus in the middle of a broader move in oncology toward more targeted therapies and data driven trial design. It also connects directly to rising demand for real world data as a complement to traditional clinical trial datasets. Looking ahead, the collaboration may influence how Tempus AI is perceived as a platform partner
Show less
Read more
Impact Snapshot
Event Time:
DSNKY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSNKY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSNKY alerts
High impacting DAIICHI SANKYO S/ADR news events
Weekly update
A roundup of the hottest topics
DSNKY
News
- ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation [Yahoo! Finance]Yahoo! Finance
- Can Tempus AI's (TEM) ALERT Trial Quietly Redefine Its Real-World Data Advantage in Cardiology? [Yahoo! Finance]Yahoo! Finance
- Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo [Seeking Alpha]Seeking Alpha
- Daiichi Sankyo's ADC Alliances Test Valuation Gap In Oncology Strategy [Yahoo! Finance]Yahoo! Finance
- Tempus Announces Strategic Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Clinical Differentiation Across an ADC Clinical ProgramBusiness Wire